Astellas Patient Assistance Program
The Astellas Patient Assistance Program provides ASTAGRAF XL® (tacrolimus extended-release capsules) at no cost to patients who meet the program eligibility requirements.
ASTAGRAF XL Support Solutionsa can assess whether the patient meets the eligibility requirements.
The patient may be eligible if they meet the following criteria:
- Be uninsured or have insurance that excludes coverage for ASTAGRAF XLb
- Have a verifiable shipping address in the United States
- Have been prescribed ASTAGRAF XL for an FDA-approved indication
- Meet income eligibility criteria
a ASTAGRAF XL Support Solutions is a component of Astellas Pharma Support SolutionsSM.
b Other insured patients may be eligible for the program if they meet certain eligibility criteria.